共 29 条
- [23] Intense cholesterol lowering therapy with a HWG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes -: A multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (06) : 324 - 330
- [24] Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trial JOURNAL OF DIABETES INVESTIGATION, 2020, 11 (06) : 1551 - 1563